Kianna Underwood: “All That” Star Dies in Hit and Run
- The Inflation Reduction Act of 2022 (IRA) is a landmark United States federal law enacted on August 16, 2022, primarily focused on reducing healthcare costs, addressing climate change,...
- signed into law by President Joe Biden, the IRA represents a important investment in clean energy and climate resilience, aiming to lower carbon emissions by roughly 40% by...
- For example, the IRA provides tax credits for individuals purchasing electric vehicles and installing solar panels, and it invests billions in clean energy manufacturing.
“`html
The Inflation Reduction act of 2022
Table of Contents
The Inflation Reduction Act of 2022 (IRA) is a landmark United States federal law enacted on August 16, 2022, primarily focused on reducing healthcare costs, addressing climate change, and increasing tax revenue.
signed into law by President Joe Biden, the IRA represents a important investment in clean energy and climate resilience, aiming to lower carbon emissions by roughly 40% by 2030.It also allows Medicare to negotiate prescription drug prices,a long-sought goal of Democrats. The law is funded through a 15% corporate minimum tax on companies with over $1 billion in profits and increased IRS tax enforcement.
For example, the IRA provides tax credits for individuals purchasing electric vehicles and installing solar panels, and it invests billions in clean energy manufacturing. The Congressional Budget Office estimated the IRA would reduce the deficit by $305 billion over ten years. CBO Report
Key Provisions: Climate change & Energy
The Inflation Reduction Act dedicates approximately $369 billion to address climate change and energy security.
This funding supports a wide range of initiatives, including tax credits for renewable energy production, investments in energy efficiency, and grants for clean energy technologies. Specifically, the IRA extends and expands tax credits for solar and wind power, provides incentives for carbon capture and storage, and supports the advancement of clean hydrogen. It also establishes a Greenhouse Gas Reduction Fund at the Environmental Protection agency (EPA) to mobilize private capital for climate-pleasant projects.
As of December 2023, the Department of Energy reported that the IRA is projected to mobilize $392 billion in private sector investment in clean energy. DOE IRA One-Year Update
Healthcare Cost Reduction
A core component of the IRA is its effort to lower healthcare costs, particularly prescription drug prices.
The law allows Medicare to negotiate the prices of certain high-cost prescription drugs, starting with 10 drugs in 2026, increasing to 20 drugs by 2029. It also caps out-of-pocket prescription drug costs for Medicare beneficiaries at $2,000 per year,beginning in 2025. Furthermore, the IRA extends enhanced Affordable Care act (ACA) subsidies through 2025, preventing premium increases for millions of Americans.
The Centers for medicare & Medicaid Services (CMS) estimates that the IRA will lower health care costs for 43 million Americans.
Tax Provisions & revenue
The Inflation Reduction Act aims to raise revenue through several tax provisions,primarily targeting large corporations.
The most significant change is a 15% minimum tax on corporations with annual profits exceeding $1 billion, as outlined in IRS guidance. This provision is designed to ensure that profitable companies pay a minimum level of tax, even if they utilize deductions and credits.The IRA also increases funding for the Internal revenue Service (IRS) to improve tax enforcement, with the goal of collecting an estimated $124 billion in additional revenue over ten years.
According to the Joint Committee on Taxation, the corporate alternative minimum tax is projected to generate $223.4 billion in revenue between 2023 and 2032. JCT Analysis
Legal Challenges and Implementation
The Inflation Reduction Act has faced legal challenges, primarily concerning the constitutionality of certain provisions.
Several lawsuits were filed challenging the law’s provisions related to prescription drug price negotiation, arguing that they violate the Fifth Amendment’s Takings Clause. In December 2023, the Supreme Court declined to hear a challenge to the law, allowing the drug price negotiation provisions to move forward.